Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Molecular “dissection” of TNBC to identify therapeutic targets

Date

09 Oct 2016

Session

Triple negative breast cancer: Do we now have something to be positive about?

Presenters

Fabrice André

Authors

F. André

Author affiliations

  • Breast Cancer Unit, Department Of Medical Oncology, Institut de Cancérologie Gustave Roussy, 94805 - Villejuif/FR
More

Resources

Reserved to ESMO members
View the presentation

Resources from the same session

Introduction: The current landscape

Presenter: Elzbieta Senkus-Konefka

Session: Triple negative breast cancer: Do we now have something to be positive about?

Resources:

Presentation

Immunotherapeutic approaches

Presenter: Peter Schmid

Session: Triple negative breast cancer: Do we now have something to be positive about?

Resources:

Presentation

Androgen receptor blockade

Presenter: Hervé Bonnefoi

Session: Triple negative breast cancer: Do we now have something to be positive about?

Resources:

Presentation

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings